These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

373 related items for PubMed ID: 28634617

  • 1. Liver transplantation for hepatocellular carcinoma.
    Berumen J, Hemming A.
    Abdom Radiol (NY); 2018 Jan; 43(1):185-192. PubMed ID: 28634617
    [Abstract] [Full Text] [Related]

  • 2. Do We Need to Be Limited by Matching Milan Criteria for Survival in Living Donor Liver Transplantation?
    Akbulut S, Koc C.
    J Gastrointest Cancer; 2020 Dec; 51(4):1107-1113. PubMed ID: 32857265
    [Abstract] [Full Text] [Related]

  • 3. Liver transplantation beyond or downstaging within the Milan criteria for hepatocellular carcinoma.
    Rudnick SR, Russo MW.
    Expert Rev Gastroenterol Hepatol; 2018 Mar; 12(3):265-275. PubMed ID: 29231769
    [Abstract] [Full Text] [Related]

  • 4. Favorable Long-term Outcome in Patients Submitted to Liver Transplantation After Downstaging of Hepatocellular Carcinoma According to a Brazilian Selection Protocol.
    Massarollo PC, Coppini AZ, Salzedas-Netto AA, Coelho FF, Minami T, Gonzalez AM.
    Transplant Proc; 2016 Sep; 48(7):2338-2340. PubMed ID: 27742292
    [Abstract] [Full Text] [Related]

  • 5. Liver Resection and Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria.
    Zaydfudim VM, Vachharajani N, Klintmalm GB, Jarnagin WR, Hemming AW, Doyle MB, Cavaness KM, Chapman WC, Nagorney DM.
    Ann Surg; 2016 Oct; 264(4):650-8. PubMed ID: 27433910
    [Abstract] [Full Text] [Related]

  • 6. Liver Transplantation for Hepatocellular Carcinoma Beyond the Milan Criteria.
    Gunsar F.
    Exp Clin Transplant; 2017 Mar; 15(Suppl 2):59-64. PubMed ID: 28302001
    [Abstract] [Full Text] [Related]

  • 7. Section 3. Current status of downstaging of hepatocellular carcinoma before liver transplantation.
    Sharr WW, Chan SC, Lo CM.
    Transplantation; 2014 Apr 27; 97 Suppl 8():S10-7. PubMed ID: 24849822
    [Abstract] [Full Text] [Related]

  • 8. Hepatic resection for transplantable hepatocellular carcinoma for patients within Milan and UCSF criteria.
    Chua TC, Saxena A, Chu F, Morris DL.
    Am J Clin Oncol; 2012 Apr 27; 35(2):141-5. PubMed ID: 21336092
    [Abstract] [Full Text] [Related]

  • 9. Beyond Milan criteria--chances and risks of expanding transplantation criteria for HCC patients with liver cirrhosis.
    Koschny R, Schmidt J, Ganten TM.
    Clin Transplant; 2009 Dec 27; 23 Suppl 21():49-60. PubMed ID: 19930317
    [Abstract] [Full Text] [Related]

  • 10. Pilot study of living donor liver transplantation for patients with hepatocellular carcinoma exceeding Milan Criteria (Barcelona Clinic Liver Cancer extended criteria).
    Llovet JM, Pavel M, Rimola J, Diaz MA, Colmenero J, Saavedra-Perez D, Fondevila C, Ayuso C, Fuster J, Ginès P, Bruix J, Garcia-Valdecasas JC.
    Liver Transpl; 2018 Mar 27; 24(3):369-379. PubMed ID: 29140601
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Predictors of outcome after liver transplantation for hepatocellular carcinoma (HCC) beyond Milan criteria.
    Halazun KJ, Sapisochin G, von Ahrens D, Agopian VG, Tabrizian P.
    Int J Surg; 2020 Oct 27; 82S():61-69. PubMed ID: 32707331
    [Abstract] [Full Text] [Related]

  • 18. Is Macroscopic Portal Vein Tumor Thrombosis of HCC Really an Exclusion for Liver Transplantation?
    Aydin C, Yilmaz S.
    J Gastrointest Cancer; 2020 Dec 27; 51(4):1137-1140. PubMed ID: 32833219
    [Abstract] [Full Text] [Related]

  • 19. Feasibility of salvage liver transplantation for patients with recurrent hepatocellular carcinoma.
    Hu RH, Ho MC, Wu YM, Yu SC, Lee PH.
    Clin Transplant; 2005 Apr 27; 19(2):175-80. PubMed ID: 15740552
    [Abstract] [Full Text] [Related]

  • 20. Effects of loco regional treatments before living donor liver transplantation on overall survival and recurrence-free survival in South Korean patients with hepatocellular carcinoma.
    Na GH, Kim EY, Hong TH, You YK, Kim DG.
    HPB (Oxford); 2016 Jan 27; 18(1):98-106. PubMed ID: 26776857
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.